These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088 [TBL] [Abstract][Full Text] [Related]
6. Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant. Sunami T; Yamada A; Kondo T; Kanai M; Nagai K; Uchida Y; Yokode M; Matsumori T; Uza N; Murakami H; Yamada T; Muto M Pancreas; 2022 Oct; 51(9):1258-1262. PubMed ID: 37078954 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901 [TBL] [Abstract][Full Text] [Related]
8. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature. Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108 [TBL] [Abstract][Full Text] [Related]
9. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154 [TBL] [Abstract][Full Text] [Related]
10. RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma. Xie F; Ding D; Lin C; Cunningham D; Wright M; Javed AA; Azad N; Lee V; Donehower R; De Jesus-Acosta A; Le DT; Pishvaian M; Shin EJ; Lennon AM; Khashab M; Singh V; Klein AP; Roberts NJ; Hacker-Prietz A; McPhaul T; Burkhart RA; Burns WR; Narang A; Zaheer A; Fishman EK; Thompson ED; Anders R; Yu J; He J; Wolfgang CL; Zheng L; Liu D; Wu K; Laheru DA JCO Precis Oncol; 2022 Jun; 6():e2100404. PubMed ID: 35737913 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Shao C; Wan J; Lam FC; Tang H; Marley AR; Song Y; Miller C; Brown M; Han J; Adeboyeje G Environ Mol Mutagen; 2022 Jul; 63(6):308-316. PubMed ID: 36054589 [TBL] [Abstract][Full Text] [Related]
13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
14. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC. Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563 [TBL] [Abstract][Full Text] [Related]
16. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors. Al-Hader A; Al-Rohil RN; Han H; Von Hoff D World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer. Chao A; Chang TC; Lapke N; Jung SM; Chi P; Chen CH; Yang LY; Lin CT; Huang HJ; Chou HH; Liou JD; Chen SJ; Wang TH; Lai CH Oncotarget; 2016 Dec; 7(51):85529-85541. PubMed ID: 27907908 [TBL] [Abstract][Full Text] [Related]
19. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. Filippova OT; Selenica P; Pareja F; Vahdatinia M; Zhu Y; Pei X; Riaz N; Long Roche K; Chi DS; Abu-Rustum NR; Ellenson LH; Reis-Filho JS; Zamarin D; Weigelt B Gynecol Oncol; 2021 May; 161(2):545-552. PubMed ID: 33674143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]